Up a level |
Jump to: 2020
Number of items: 1.
2020
Ladwig, A., Suh, J., Schweitzer, F., Roeth, P., Remke, G., Warnke, C., Schroeter, M., Izquierdo-Alvarez, E., Bonmann, E., Fink, G. R., Pallasch, C. and Lehmann, H. (2020). Alemtuzumab induces changes in the innate immune system in patients with relapsing-remitting multiple sclerosis. Mult. Scler. J., 26 (3_SUPPL). S. 259 - 260. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970